Free Trial

Q2 EPS Estimates for Owens & Minor Lifted by Leerink Partnrs

Owens & Minor logo with Medical background

Owens & Minor, Inc. (NYSE:OMI - Free Report) - Equities research analysts at Leerink Partnrs raised their Q2 2025 earnings per share estimates for shares of Owens & Minor in a research note issued on Thursday, May 8th. Leerink Partnrs analyst M. Cherny now forecasts that the company will post earnings per share of $0.30 for the quarter, up from their prior forecast of $0.29. The consensus estimate for Owens & Minor's current full-year earnings is $1.51 per share. Leerink Partnrs also issued estimates for Owens & Minor's Q3 2025 earnings at $0.53 EPS, FY2025 earnings at $1.63 EPS and FY2028 earnings at $2.76 EPS.

A number of other analysts also recently commented on OMI. UBS Group cut their price objective on shares of Owens & Minor from $25.00 to $13.00 and set a "buy" rating for the company in a report on Thursday, February 13th. Robert W. Baird increased their price objective on shares of Owens & Minor from $10.00 to $11.00 and gave the company a "neutral" rating in a report on Monday, March 3rd. Citigroup cut their price objective on shares of Owens & Minor from $13.00 to $11.00 and set a "buy" rating for the company in a report on Thursday, April 17th. Finally, JPMorgan Chase & Co. lowered their price target on shares of Owens & Minor from $14.00 to $10.00 and set an "underweight" rating on the stock in a research report on Monday, March 10th. Two analysts have rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company's stock. According to MarketBeat, Owens & Minor currently has an average rating of "Hold" and an average target price of $12.50.

View Our Latest Research Report on Owens & Minor

Owens & Minor Price Performance

OMI stock traded up $0.10 during mid-day trading on Monday, reaching $7.25. The company's stock had a trading volume of 1,368,668 shares, compared to its average volume of 1,124,334. The stock has a market cap of $560.10 million, a PE ratio of -11.15, a P/E/G ratio of 0.20 and a beta of 1.38. The company has a current ratio of 1.09, a quick ratio of 0.45 and a debt-to-equity ratio of 2.11. Owens & Minor has a fifty-two week low of $6.07 and a fifty-two week high of $21.02. The company's 50 day moving average is $8.02 and its two-hundred day moving average is $10.70.

Owens & Minor (NYSE:OMI - Get Free Report) last posted its earnings results on Saturday, May 10th. The company reported $0.23 EPS for the quarter, beating analysts' consensus estimates of $0.20 by $0.03. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. Owens & Minor's revenue was up .7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.19 EPS.

Hedge Funds Weigh In On Owens & Minor

Institutional investors have recently bought and sold shares of the company. American Century Companies Inc. raised its stake in shares of Owens & Minor by 15.3% in the first quarter. American Century Companies Inc. now owns 210,338 shares of the company's stock valued at $1,899,000 after acquiring an additional 27,851 shares in the last quarter. Fox Run Management L.L.C. acquired a new stake in shares of Owens & Minor in the first quarter valued at $419,000. LHM Inc. grew its holdings in Owens & Minor by 66.6% during the 1st quarter. LHM Inc. now owns 292,942 shares of the company's stock worth $2,645,000 after acquiring an additional 117,150 shares in the last quarter. Public Sector Pension Investment Board grew its holdings in Owens & Minor by 27.3% during the 1st quarter. Public Sector Pension Investment Board now owns 234,393 shares of the company's stock worth $2,117,000 after acquiring an additional 50,275 shares in the last quarter. Finally, Nuveen LLC acquired a new position in Owens & Minor during the 1st quarter worth approximately $3,729,000. 98.04% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, major shareholder Coliseum Capital Management, L bought 225,000 shares of the company's stock in a transaction on Wednesday, April 9th. The stock was bought at an average cost of $7.39 per share, with a total value of $1,662,750.00. Following the transaction, the insider now directly owns 11,482,955 shares in the company, valued at $84,859,037.45. The trade was a 2.00% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders acquired a total of 2,718,412 shares of company stock valued at $24,495,308 over the last quarter. 3.69% of the stock is owned by insiders.

Owens & Minor announced that its Board of Directors has authorized a stock repurchase program on Friday, February 28th that allows the company to buyback $100.00 million in outstanding shares. This buyback authorization allows the company to reacquire up to 13.6% of its shares through open market purchases. Shares buyback programs are generally a sign that the company's board believes its shares are undervalued.

Owens & Minor Company Profile

(Get Free Report)

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.

See Also

Should You Invest $1,000 in Owens & Minor Right Now?

Before you consider Owens & Minor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Owens & Minor wasn't on the list.

While Owens & Minor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs Warns of 20% Market Drop—Are They Right?
Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines